How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,242 results for

ADHD Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD

Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03446885 Recruitment

2017 Clinical Trials

62. Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD)

Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD) Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03363568 Recruitment Status : Completed First Posted : December 6, 2017 Last Update Posted : December 12, 2017 Sponsor: Boston Children’s Hospital Collaborator: Neuroscouting, L.L.C

2017 Clinical Trials

63. Effects of prenatal alcohol consumption on cognitive development and ADHD-related behaviour in primary-school age: a multilevel study based on meconium ethyl glucuronide. (PubMed)

cognitive development was measured using an IQ test battery, and event-related potentials were recorded during a cued go/nogo task.Children in both EtG-positive groups allocated fewer attentional resources than controls to the go/nogo task (reduced P3 component in go-trials). Children with a meconium EtG above 154 ng/g were also found to have an IQ that was six points lower than the other groups. Within the EtG ≥ 154 ng/g group, there was a positive correlation between EtG value and ADHD-related (...) behaviour. These significant effects were not observed in relation to the maternal self-report data.Associations between EtG and cognitive deficits, attentional resource capacity and ADHD-related behaviour could be documented with effects that were partially dose-dependent. In addition to maternal self-reports, this biomarker of intrauterine alcohol exposure may be considered as a predictor of child development.© 2017 Association for Child and Adolescent Mental Health.

2017 Journal of Child Psychology and Psychiatry

64. ADHD patients fail to maintain task goals in face of subliminally and consciously induced cognitive conflicts. (PubMed)

to be endowed with a threshold which allows them to maintain high behavioural performance in the face of low conflict load. ADHD patients seem to lack sufficient top-down attentional resources to maintain correct response selection in the face of conflicts by shielding the response selection process from response tendencies evoked by any kind of distractor. (...) ADHD patients fail to maintain task goals in face of subliminally and consciously induced cognitive conflicts. Attention deficit hyperactivity disorder (ADHD) patients have been reported to display deficits in action control processes. While it is known that subliminally and consciously induced conflicts interact and conjointly modulate action control in healthy subjects, this has never been investigated for ADHD.We investigated the (potential) interaction of subliminally and consciously

2017 Psychological Medicine

65. A Randomized Controlled Study of MEFP for Preschool Children With ADHD

Function Training for Preschool Children With ADHD - A Randomized Controlled Study Actual Study Start Date : June 1, 2017 Estimated Primary Completion Date : December 2018 Estimated Study Completion Date : December 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Intervention group Subjects in this group will receive the "Metacognitive Executive Function Training (MEFP)" program in aiming to reduce (...) A Randomized Controlled Study of MEFP for Preschool Children With ADHD A Randomized Controlled Study of MEFP for Preschool Children With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Randomized

2017 Clinical Trials

66. PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations

PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03265119 Recruitment Status : Completed First Posted : August 29, 2017 Last Update Posted : November 15

2017 Clinical Trials

67. Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD

Completion Date : January 10, 2018 Actual Study Completion Date : January 10, 2018 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Occupational Therapy for Women with ADHD 7-week tailored intervention for women with ADHD who have difficulty carrying out student, worker, spousal, and parenting roles due to poor time management, organization of their physical environments, management of internal and external (...) Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2017 Clinical Trials

68. Long-term Effects of Medication for ADHD

to Layout table for study information Study Type : Observational Estimated Enrollment : 100 participants Observational Model: Cohort Time Perspective: Prospective Official Title: Long-term Effects of Medication for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents on Cognition, Everyday Function and Quality of Life Study Start Date : April 2014 Estimated Primary Completion Date : December 2019 Estimated Study Completion Date : December 2019 Resource links provided (...) Long-term Effects of Medication for ADHD Long-term Effects of Medication for ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Long-term Effects of Medication for ADHD (LMA) The safety and scientific

2017 Clinical Trials

69. Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting

Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 103 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Mindfulness Training for Children With ADHD and Mindful Parenting Actual Study Start Date : February 18, 2016 Actual Primary Completion Date : July 26, 2018 Actual Study Completion Date : February 22, 2019 Resource links provided (...) Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2017 Clinical Trials

70. Aripiprazole Added on for DMDD in Youths With ADHD

) Actual Enrollment : 58 participants Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment Official Title: Aripiprazole Added on Methylphenidate in the Treatment of Youths With Comorbid ADHD and DMDD Actual Study Start Date : November 19, 2014 Actual Primary Completion Date : August 12, 2017 Actual Study Completion Date : August 12, 2017 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention (...) Aripiprazole Added on for DMDD in Youths With ADHD Aripiprazole Added on for DMDD in Youths With ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Aripiprazole Added on for DMDD in Youths With ADHD

2017 Clinical Trials

71. CX717 in the Treatment of Adult ADHD

CX717 in the Treatment of Adult ADHD CX717 in the Treatment of Adult ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. CX717 in the Treatment of Adult ADHD The safety and scientific validity (...) to Assess the Efficacy And Safety of the Ampakine® Compound, CX717, versus Placebo in Adults with Attention-Deficit Hyperactivity Disorder Condition or disease Intervention/treatment Phase Attention Deficit Hyperactivity Disorder Drug: CX717 200 mg Drug: CX717 800 mg Drug: Placebo Phase 2 Detailed Description: This study examined the clinical efficacy, tolerability and safety of CX717 in the treatment of adults with ADHD. The study was a double-blind, 2-period crossover study that compared 2 different

2017 Clinical Trials

72. QbTest Utility for Optimising Treatment in ADHD (QUOTA)

and Young People With Attention Deficit Hyperactivity Disorder (ADHD) Using an Objective Measure of Attention, Impulsivity and Activity (QbTest): a Feasibility Study Estimated Study Start Date : December 2017 Estimated Primary Completion Date : March 2019 Estimated Study Completion Date : March 2019 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment No Intervention: Control Arm Participants in the control arm will undergo (...) QbTest Utility for Optimising Treatment in ADHD (QUOTA) QbTest Utility for Optimising Treatment in ADHD (QUOTA) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. QbTest Utility for Optimising Treatment

2017 Clinical Trials

73. Oxytocin and Cognitive Control in Adult ADHD

Oxytocin and Cognitive Control in Adult ADHD Oxytocin and Cognitive Control in Adult ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Oxytocin and Cognitive Control in Adult ADHD The safety (...) ): Franziska Plessow, Massachusetts General Hospital Study Details Study Description Go to Brief Summary: This is a randomized, double-blind, placebo-controlled crossover study of single-dose intranasal oxytocin (24 IU) in 18-55 year-old men with attention deficit/hyperactivity disorder (ADHD). Following a screening visit to determine eligibility, participants will return for two main study visits. During the main study visits, study participants will receive either oxytocin (Syntocinon® nasal spray

2017 Clinical Trials

74. Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03260205 Recruitment Status : Completed First Posted : August

2017 Clinical Trials

75. A Brief Parent-based Sleep Intervention for ADHD Children

A Brief Parent-based Sleep Intervention for ADHD Children A Brief Parent-based Sleep Intervention for ADHD Children - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Brief Parent-based Sleep Intervention (...) for ADHD Children The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03263156 Recruitment Status : Recruiting First Posted : August 28, 2017 Last Update Posted : August 30, 2017 See Sponsor: The University of Hong Kong

2017 Clinical Trials

76. Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD

. Primary Purpose: Other Official Title: A Randomized, Sham-Controlled, Crossover Study to Evaluate the Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in Children and Adolescents Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD) Actual Study Start Date : September 21, 2018 Estimated Primary Completion Date : August 2019 Estimated Study Completion Date : August 2019 Resource links provided by the National Library of Medicine related topics: Arms (...) Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies

2017 Clinical Trials

77. A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.

Assessor) Masking Description: Double Blind Primary Purpose: Treatment Official Title: Dasotraline (2mg) in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD): A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of Efficacy and Safety in a Laboratory Classroom Setting Actual Study Start Date : July 31, 2017 Estimated Primary Completion Date : March 15, 2019 Estimated Study Completion Date : March 15, 2019 Resource links provided (...) A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information

2017 Clinical Trials

78. A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations

A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03233867 Recruitment Status : Completed First Posted : July 31, 2017 Last Update

2017 Clinical Trials

79. Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning (...) You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier

2017 Clinical Trials

80. Central Executive Training (CET) for ADHD

Type : Interventional (Clinical Trial) Estimated Enrollment : 250 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: Central Executive Training for ADHD: Efficacy Trial Actual Study Start Date : January 1, 2018 Estimated Primary Completion Date : December 31, 2022 Estimated Study Completion Date : December 31, 2022 Resource links provided (...) Central Executive Training (CET) for ADHD Central Executive Training (CET) for ADHD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Central Executive Training (CET) for ADHD The safety and scientific

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>